Skip to main content
OpenTrials
Completed

NCT Number: NCT02049255

Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia.

Comparison the use of marcaine and chloroprocaine in rachianesthesia for a surgical correction of inguinal hernia. Comparision between acute and chronic (3 months and 6 months) pain.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults under rachianesthesia

Exclusion criteria

  • Personal history of gastric ulcus
  • ASA 4
  • Emergency
  • Combined surgery

Treatment and study plan

Chloroprocaine

Drug

The Group "Chloroprocaine" will receive: Chloroprocaine: 50 mg in rachianesthesia

marcaine

Drug

The Group "Marcaine" will receive: Marcaine: 12,5 mg in rachianesthesia

Primary outcomes

  1. Acute pain

    Time frame: 1 day of the surgery when patient leave the recovery room

Secondary outcomes

  1. Chronic pain

    Time frame: at 3 and 6 months

Sponsors and collaborators

Lead sponsor

Astes

Other

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Jan 30, 2014
Registry last updated
Nov 3, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.